ALEXIS WOOD to Hypolipidemic Agents
This is a "connection" page, showing publications ALEXIS WOOD has written about Hypolipidemic Agents.
Connection Strength
1.005
-
Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN). Metabolism. 2015 Oct; 64(10):1359-71.
Score: 0.427
-
Genetic analysis of 16 NMR-lipoprotein fractions in humans, the GOLDN study. Lipids. 2013 Feb; 48(2):155-65.
Score: 0.179
-
Preliminary evidence of genetic determinants of adiponectin response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network. Nutr Metab Cardiovasc Dis. 2013 Oct; 23(10):987-94.
Score: 0.178
-
Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate. Pharmacogenet Genomics. 2012 Oct; 22(10):750-7.
Score: 0.177
-
Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate. PLoS One. 2012; 7(10):e48663.
Score: 0.044